David P Bender MD

Obstetrics & Gynecology•Iowa City, IA

Gynecologic Oncology

Clinical Professor of Obstetrics & Gynecology, University Iowa College of Medicine

Join to View Full Profile

200 Hawkins DriveSte 100Iowa City, IA 52242
Phone+1 319-356-1616
Fax+1 319-353-8363

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 2001 - 2004
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1995 - 1999
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1995

Certifications & Licensure

IA State Medical License 2000 - 2027
KY State Medical License 1999 - 2001
PA State Medical License 1996 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28
Completed
Phase 1
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14
Completed
Phase 1
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Completed
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Sexual Dysfunction in Gynecologic Oncology Patients Start of enrollment: 2019 Jun 06
Terminated
Phase 4
Roles: Contact, Sponsor-Investigator, Principal Investigator
A Phase 1 Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer Start of enrollment: 2021 Dec 31
RECRUITING
PHASE1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation.
Jesus Gonzalez Bosquet, Vincent Wagner, Andrew Polio, Katharine E Linder, David P Bender
International Journal of Molecular Sciences. 2025-02-05
2 citations
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ova...
Jubilee Brown, Austin Miller, Laura L Holman, Floor Backes, Christa Nagel
Gynecologic Oncology. 2024-11-01
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/EN...
Bhavana Pothuri, Sileny Han, Dana M Chase, Florian Heitz, Robert A Burger
Gynecologic Oncology. 2024-05-01

Press Mentions

University of Iowa Hospitals and Clinics' Pioneering Vision of Hospital Art Impacts HealingSeptember 26th, 2019